Company Overview
About Fella Health
Fella Health is a San Francisco-based men's obesity telemedicine platform — bootstrapped with minimal external funding ($130,000 seed from Y Combinator, Global Founders Capital, AngelList, and founders of Indeed, Curative, and Alan) — providing men with obesity and metabolic health challenges with a subscription-based direct-to-patient treatment program combining FDA-approved GLP-1 medications (semaglutide and tirzepatide), psychological strengthening, and behavioral interventions for significant weight loss and metabolic health improvement. Having achieved over $50 million in annual recurring revenue and cashflow positive operations for 24 months, with 76+ employees and a mission to serve 1 million men by end of 2026, Fella also operates Delilah Health for women through the same clinical model. Y Combinator W20/S21 backed.
Business Model & Competitive Advantage
Fella Health's men's obesity telemedicine model capitalizes on the GLP-1 medication revolution in obesity treatment while adding the behavioral support that clinical evidence shows improves long-term outcomes: semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) achieve 15-22% body weight reduction in clinical trials — but the drugs are expensive ($1,000-$1,300/month list price), require physician oversight, and work best when combined with lifestyle modification that sustains the metabolic changes after medication titration. Fella's subscription model (typically $150-300/month, far below GLP-1 medication list price) achieves the medication access and behavioral support combination by sourcing compounded semaglutide through FDA-registered compounding pharmacies during the branded GLP-1 supply shortage, providing physician prescribing through synchronous and asynchronous telemedicine consultations, and delivering the health coaching that supports sustainable behavior change alongside the medication.
Competitive Landscape 2025–2026
In 2025, Fella Health competes in the men's health telemedicine, GLP-1 obesity treatment, and direct-to-consumer metabolic health market with Ro (men's health telehealth, $876M raised at $5B valuation), Calibrate (metabolic health program, $100M raised), and Hims & Hers (NYSE: HIMS, men's and women's telehealth, $526M revenue 2024) for men with obesity and metabolic health telemedicine program adoption. The $50M+ ARR with $130K in external funding represents one of the most capital-efficient telehealth companies in the GLP-1 obesity treatment market. The cashflow positive milestone (24 months) demonstrates the business model sustainability that VC-heavy telehealth competitors have not yet achieved. The 2025 strategy focuses on the expansion to Fella's 1 million patient milestone, building the metabolic health monitoring platform for longitudinal GLP-1 treatment outcomes tracking, and growing the Delilah women's health brand as a parallel market opportunity.
Recent Activity
View all →Key Differentiators
Strong Challenger
Fella Health is an established challenger with significant market presence and competitive offerings in Healthcare.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
S2
S2 is an AI-powered security platform focused on vulnerability discovery and attack surface management for enterprise security teams. The company's platform combines automated scanning, AI-powered ana
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Compare Fella Health with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Fella Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Fella Health Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Fella Health vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →